As asthma and sinusitis remained clinically stable and peripheral eosinophil count was at 53 × 109/l (1%), IFN-induced neuropathy was suspected, which remained after switching treatment to PEG-IFN-α. This evidence concerns the gene IFNA2 and neuropathy.